| Principal Investigator |
Title |
IRB#: |
| Gabbard, Julie |
Retrospective Medical Record Review, the Donation Process |
1991-022 |
| Golden, Carla MD |
A Protocol for Collecting Follow-Up Data on Children's Cancer Group (and Other) Studies CHO-LFTU-1 |
1996-014 |
| Golden, Carla MD |
Escalating Dose Intravenous Methotrexate
without Leucovorin Rescue vs Oral
Methotrexate and Single vs Double Delayed
Intensification Therapy for Children with
Standard Risk Acute Lymphoblastic Leukemia (COG 1991) |
2000-049 |
| Golden, Carla MD |
Osteosarcoma Biology Protocol (COG 9851) |
2001-054 |
| Golden, Carla MD |
Neuroblastoma Biology Studies (ANBL00B1) |
2001-058 |
| Golden, Carla MD |
National Wilms' Tumor Late Effects (COG 4941L) |
1996-005 |
| Golden, Carla MD |
A Phase III Group Wide Study of Dose Intensive, Response Based Chemotherapy and Radiation Therapy for Children and Adolescents with Newly Diagnosed Intermediate Risk Hodgkin's Disease (AHOD0031) |
2003-047 |
| Golden, Carla MD |
A Group-Wide Biology and Banking Study for Ewing Sarcoma: COG-AEWS02B1 |
2003-063 |
| Golden, Carla MD |
Perinatal Neuroblastoma: Expectant Observation (COG ANBL00P2) |
2004-108 |
| Golden, Carla MD |
High Risk B-Precursor Acute Lymphoblastic Leukemia, A Phase III Group-Wide Study (COG AALL0232) |
2004-025 |
| Golden, Carla MD |
Classification of Acute Lymphoblastic Leukemia for Collection of Additional Bone Marrow (AALL03B1) |
2004-027 |
| Golden, Carla MD |
A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Germ Cell Tumors |
2004-049 |
| Golden, Carla MD |
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial ACNS00331 |
2004-085 |
| Golden, Carla MD |
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid Rhabdomyosarcoma (ARST0331) |
2005-100 |
| Golden, Carla MD |
A Phase II study of hu14.18-IL2 (BB-IND-9728) in Children with Recurrent or Refractory Neuroblastoma (COG-ANBL0322) |
2005-104 |
| Golden, Carla MD |
A Groupwide Randomized Phase II Window Study of Two Different Schedules of Ironotecan in Combination with Vincristine and Pilot Assessment of Safety and Efficacy of Tirapazamine Combined with Multiagent Chemotherapy for First Relapse of Progres (ARST0121) |
2005-015 |
| Golden, Carla MD |
Standard Risk B-Precursor Acute Lymphoblastic Leukemia (COG AALL0331) |
2005-050 |
| Golden, Carla MD |
Key Adverse Events Following Childhood Cancer (ALTE03N1) |
2005-059 |
| Golden, Carla MD |
Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue (ANBL0032) |
2005-007 |
| Golden, Carla MD |
Treatment of Late Isolated Extramedullary Relapse from Acute Lymphoblastic Leukemia (ALL) (initial CR1> 18 Months) (AALL02P2) |
2005-008 |
| Golden, Carla MD |
A Phase II Study of Aerosolized GM-CSF (NSC#613795, IND #11042) in Patients with First Pulmonary Recurrence of Osteosarcoma (AOST0221) |
2005-009 |
| Golden, Carla MD |
Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol, (COG-D9902) |
2006-012 |
| Golden, Carla MD |
A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histologic Response to Pre-Operative Chemotherapy (EURAMOS 1) (AOST0331) |
2006-017 |
| Golden, Carla MD |
Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors (COG ABTR01B1) |
2006-034 |
| Golden, Carla MD |
Renal Tumors Classification, Biology and Banking Study (COG-AREN03B2) |
2006-050 |
| Golden, Carla MD |
A Phase II Study of Irinotecan + Temozolomide in Children with Recurrent Neuroblastoma (COG-ANBL0421) |
2006-059 |
| Golden, Carla MD |
Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients with High-Risk Rhabdomyosarcoma (ARST0431) |
2006-087 |
| Golden, Calra MD |
A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults (AAML0531) |
2006-083 |
| Golden, Calra MD |
Intensified Methotrexate, Nelarabine (Compound 506U78; IND # 52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (AALL0434) |
2007-019 |
| Golden, Calra MD |
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS) (ARST0531) |
2007-041 |
| Golden, Calra MD |
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors (AREN0533) |
2007-042 |
| Golden, Calra MD |
Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies AALL0433) |
2007-055 |
| Golden, Calra MD |
ANBL0531: Response and Biology-Based Therapy for Intermediate-Risk Neuroblastoma |
2007-080 |
| Golden, Calra MD |
A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND#76431; NSC#617807) (AALL0631) |
2008-027 |
| Golden, Calra MD |
Collecting and Banking Ewing Sarcoma Specimens (AEWS07B1) |
2008-036 |
| Gomez, Ann PhD, RCP, |
Survey of Staff with Experience Using Heat Humidified Nasal Cannula Therapy |
2005-056 |
| Granoff, Dan MD |
Human Serum for Use in Bactericidal Assays |
2002-010 |
| Granoff, Dan MD |
Expedited Review of a Proposed Investigation on Stored Sera from Uganda |
2002-020 |
| Granoff, Dan MD |
Expedited Review of Proposed Investigations of Stored Sera: Sudan Study |
2002-023 |
| Granoff, Dan MD |
Expedited Review of Proposed Investigations of Stored Sera: GSK Meningococcal Conjugate and Polysaccharide Immunogenicity Study: Czech Republic/Belgium |
2002-024 |
| Granoff, Dan MD |
Immunity to Meningococcal Polysaccharide Vaccine (Menomune) |
2002-034 |
| Granoff, Dan MD |
Expedited Review of Proposed Investigations of Stored Sera: Oakland |
2002-036 |
| Granoff, Dan MD |
Proposed Investigations of Stored Sera: Canadian Meningococcal Immunogenicity Study |
2002-006 |
| Granoff, Dan MD |
A Phase 2, Randomized, Single-Center, Controlled Study to Evaluate the Safety, Immunogenicity and Priming Ability of the Chiron Meningococcal C Conjugate Vaccine in Adults at Risk for Meningococcal Serogroup C Exposure or Disease |
2003-016 |
| Granoff, Dan MD |
A Phase I, Open-Label, Uncontrolled, Single-Center, Extension Study of the Safety, Tolerability, and Immunogenicity of the Chiron Recombinant Meningococcal B G 287 Vaccine in Healthy Adults who Previously Completed Study MB1001 |
2004-018 |
| Granoff, Dan MD |
Expedited Review of Proposed Investigations Using Whole Blood for Bacterial Growth Assays |
2004-039 |
| Granoff, Dan MD |
Human Serum for Use in Bactericidal Assays: Screening to Find Suitable Donors (Aventis Study) |
2005-002 |
| Granoff, Dan MD |
Human Serum for Use as Complement: Collection from Previously Identified Donors (Sanofi Study) |
2005-068 |
| Greenhow, Tara MD |
A Phase 3 Randomized Double-Blind Multicenter Study to Compare the Efficacy and Safety of Micafungin versus Amphotericin B Deoxycholate for the Treatment of Neonatal Candidiasis |
2006-044 |
| Hagar, Ward MD |
ER and Hospitalization Utilization Patterns Before and After Joining a Comprehensice Sickle Cell Center |
2005-073 |
| Hagar, Ward MD |
Doppler Ultrasound Screening in Adult Sickle Cell Patients |
2007-045 |
| Hardy, Karen MD |
Cystic Fibrosis Patient Registry |
2003-001 |
| Hardy, Karen MD |
Barriers to Adherence in Giving Inhaled Corticosteriods to Children with Chronic Persistent Asthma |
2004-071 |
| Hardy, Karen MD |
Retrospective Review of Children’s Hospital & Research Center at Oakland (CHRCO) Experience with Tonsillectomy & Adenoidectomy- Description of the Changing Face of Obstructive Sleep Apnea Syndrome |
2006-038 |
| Hardy, Karen MD |
Genetic Modifiers of Cystic Fibrosis: Twin and Sibling Study |
2006-005 |
| Hardy, Karen MD |
A Multi-Center, Double-Blind, Placebo-controlled Randomized, Efficacy and Safety Study of Denufosol Tetrasodium (INS 37217) Inhalation Solution in Patients with Mild Cystic Fibrosis Lung Disease |
2006-057 |
| Hardy, Karen MD |
Antimicrobial Resistance in Sputum Obtained from Patients with Cystic Fibrosis (CF |
2006-066 |
| Hardy, Karen MD |
Genetic Modifiers in Cystic Fibrosis Lung and Liver Disease (version 13 July 2005) |
2006-072 |
| Hardy, Karen MD |
Retrospective Review of Alveolar Hemorrhage of CHRCO experience in past 30 years |
2007-023 |
| Harmatz, Paul MD |
Prevalence and Predictors of Altered Iron Metabolism in Children with Immunodeficiency |
2002-070 |
| Harmatz, Paul MD |
Natural History of Iron Burden and Risk of Organ Injury as Assessed and Predicted by Non-Invasive Measurement Techniques |
2002-075 |
| Harmatz, Paul MD |
Validation of Biosusceptometry as a Non-Invasive Technique for Assessment of Liver Iron |
2003-026 |
| Harmatz, Paul MD |
Calibration of SQUID Biosusceptometry Instruments as a Non-Invasive Technique for Assessment of Liver Iron |
2003-076 |
| Harmatz, Paul MD |
Gender, Obesity, C-Reactive Protein and Oxidative Stress |
2004-033 |
| Harmatz, Paul MD |
A Phase 3 Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents (Age 2 to <18) with Chronic Hepatitis B |
2004-076 |
| Harmatz, Paul MD |
Early Detection of Iron Cardiomyopathy in Thalassemia (EDICT |
2005-011 |
| Harmatz, Paul MD |
A Phase 4 Multi-Center, Multi-National, Open-Label, Randomized, Two Dose Level Study of Naglazyme (galsulfase) in Infants with Maroteaux-Lamy Syndrome (MPS VI) |
2005-101 |
| Harmatz, Paul MD |
A Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I (MIRC-001) |
2005-103 |
| Harmatz, Paul MD |
Pathologic Markers of Genetic Damage and Disease in Inflammatory Bowel Disease (IBD) |
2005-012 |
| Harmatz, Paul MD |
MPS VI Clinical Surveillance Program |
2005-062 |
| Harmatz, Paul MD |
Magnetic Resonance Imaging (MRI) Protocol Development and Quality Assurance |
2005-064 |
| Harmatz, Paul MD |
Comparison between a Low Cost Cryobiosusceptometer and Ferritometer as a Non-Invasive Technique for Assessment of Liver Iron |
2006-010 |
| Harmatz, Paul MD |
Quantification of Cardiac Iron Concentration in Cooley's Anemia by MRI Susceptometry |
2006-022 |
| Harmatz, Paul MD |
Calibration of MRI T2* Methodology for Cardiac Iron Assessment in B Thalassemia Patients with Transfusional Iron Overload; Study # CICL670A US11 |
2006-025 |
| Harmatz, Paul MD |
An open label trial evaluating cardiac T2* in ß-thalassemia patients on deferasirox (ICL 670) treatment for 18 months (CICL670AUS04) |
2006-027 |
| Harmatz, Paul MD |
Hunter Outcome Survey (HOS): A Global, Multi-Center, Long-Term, Observational Survey of Patients with Hunter Syndrome (Mucopolysaccharidosis II) |
2006-067 |
| Harmatz, Paul MD |
A Multi-Center, Open-Labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients with Constipation SPI/0211SC-0641 |
2007-002 |
| Harmatz, Paul MD |
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease Previously Treated with Imiglucerase |
2007-047 |
| Hoffinger, Scott MD |
Assessment of Upper Extremity Bone Mineral Density (BMD) Variability in Healthy Pediatric Participants |
2005-026 |
| Hoppe, Carolyn MD |
Genetic Predictors for Stroke in Children with Sickle Cell Anemia |
1999-001 |
| Hoppe, Carolyn MD |
Phase I/II Study of Simvastatin (Zocur) Therapy in Sickle Cell Disease |
2006-037 |
| Hoppe, Carolyn MD |
Comprehensive Sickle Cell Centers (CSCC) Collaborative Genotype-Phenotype Database and Sample Repository |
2006-093 |
| Hoppe, Carolyn MD |
Do silent infarcts occur in children with sickle cell disease who are chronically transfused for cerebrovascular accidents? |
2007-053 |
| Hoppe, Carolyn MD |
Analysis of Rh Blood Group Genes to Improve Transfusion Therapy in Sickle Cell Disease |
2007-061 |
| Houtchens, Kathleen PhD |
Novel MALDI-TOF Assay for Rapid KIR Complex Sequencing |
2004-090 |
| Hsieh, Charlotte MD |
Use of Throw-Away Samples for Validation of In-House PCR Assays |
2005-023 |
| Illek, Beate PhD |
Translational Research Center for CAM Therapy and Asthma |
2005-031 |
Cholesterol Research Center 
Thalassemia Clinical Research Network
